Iceland - August 15, 2022
First report from the largest whole genome sequencing effort
Scientists at deCODE genetics together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature. This is the first report from the largest whole genome sequencing effort to date where scientists from deCODE genetics and the Wellcome Trust Sanger […]
Biotech Business - June 16, 2022
Alvotech debuts on Nasdaq
Alvotech has announced that its ordinary shares and warrants will begin trading on the Nasdaq Stock Market LLC on Thursday, June 16, under the new ticker symbols “ALVO” and “ALVOW”, respectively. This follows the completion of the company’s business combination with Oaktree Acquisition Corp. II (“OACB”), a special purpose acquisition company sponsored by an affiliate […]
Iceland - May 27, 2022
Alvotech improves access to capital and streamlines path to expected public listing
Alvotech and Oaktree Acquisition Corp II establish financing facilities to enhance the company’s capital position and to replace any redeemed capital as part of their proposed merger. The two parties agree to reduce the minimum cash condition outlined in the merger agreement, thereby enhancing deal certainty in their proposed business combination. In late 2021, Alvotech […]
Financing - February 23, 2022
Coripharma secures 24.5 million EUR in funding
Coripharma has secured equity funding to further support its future growth through research and development of generic pharmaceutical products in addition to increased commercial outreach. The financing round is in line with the company’s previously communicated plans and attracted significant interest from large institutional investors, including Icelandic pension funds, as well as receiving strong support […]
Iceland - January 26, 2022
The largest ever study of the plasma proteome
Scientists at deCODE genetics have demonstrated how measuring the levels of a large number of proteins in plasma at a population scale when combined with data on sequence diversity and RNA expression dramatically increases insights into human diseases and other phenotypes. The scientists have used levels of five thousand proteins in plasma targeted on a […]
Agreement - December 8, 2021
Alvotech and Oaktree announce merger agreement
Alvotech and Oaktree Acquisition Corp II, a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, have entered into a definitive merger agreement. Upon completion of the transaction, the combined company’s securities are expected to be traded on NASDAQ under the symbol “ALVO.” “Alvotech is in a unique position to impact the […]
